Document Detail


Ebselen protects against the reduction in levels of drug-metabolizing enzymes in livers of rats with deoxycholic acid-induced liver injury.
MedLine Citation:
PMID:  12420794     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ebselen is a seleno-organic compound that inhibits oxidative stress by lipid peroxidation through a glutathione peroxidase-like activity. We studied the effect of ebselen on the expression of hepatic drug-metabolizing enzymes in rats with deoxycholic acid-induced liver injury. Hydrophobic bile acids, such as deoxycholic acid, are known to cause cholestatic liver injury, and it was reported that expression of hepatic cytochrome P-450 (CYP) was reduced by deoxycholic acid administration in rats. Hydrophobic bile acids induce lipid peroxidation in the liver, and this may be one mechanism of the development of liver injury. In the present study, we investigated the effect of ebselen (30 mg/kg/day for 10 days) on rats ingesting deoxycholic acid (1% of diet for 10 days). Deoxycholic acid decreased levels of CYP1A1, 2B1, 2E1 and 3A2 to 34, 58, 62 and 37% of control values, respectively, and increased serum alkaline phosphatase (ALP) and alanine aminotransferase (ALT) activities to 1.8 and 8.6 times the levels of controls, respectively. Administration of ebselen with deoxycholic acid prevented the decreases in levels of CYP1A1 and 3A2 (86 and 65% of control, respectively) and the increases in serum ALP and ALT activities (1.4 and 1.9 times of control, respectively) caused by deoxycholic acid. These results indicate that ebselen may have a protective effect against hydrophobic bile acid-induced liver injury.
Authors:
Masami Tanaka; Nahomi Takezawa; Toshio Kumai; Minoru Watanabe; Naoki Matsumoto; Sachiko Nakaya; Shinichi Kobayashi
Related Documents :
1542054 - Metabolism of long chain fatty acids by ruminant liver.
206354 - Turnover of messenger rna in transplantable hepatomas and host liver of rats.
3652284 - Characterization of tannic acid metabolites formed in vitro by rat liver microsomes and...
2260084 - Difference in enzymatic sulfation of bile acids between the mouse and rat.
4086434 - Hydrolysate preparation for analysis of amino acids in sorghum grains: effect of oxidat...
12093284 - The biosynthetic incorporation of short-chain linear saturated fatty acids by acholepla...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pharmacology & toxicology     Volume:  91     ISSN:  0901-9928     ISO Abbreviation:  Pharmacol. Toxicol.     Publication Date:  2002 Aug 
Date Detail:
Created Date:  2002-11-07     Completed Date:  2003-03-04     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8702180     Medline TA:  Pharmacol Toxicol     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  64-70     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, St Marianna University School of Medicine, Kawasaki, Japan. m3tanaka@marianna-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alanine Transaminase / metabolism
Alkaline Phosphatase / metabolism
Animals
Antioxidants / therapeutic use*
Azoles / therapeutic use*
Cytochrome P-450 Enzyme System / metabolism
Deoxycholic Acid / adverse effects
Drug-Induced Liver Injury / drug therapy*,  enzymology,  metabolism
Male
Organoselenium Compounds / therapeutic use*
Rats
Rats, Sprague-Dawley
Chemical
Reg. No./Substance:
0/Antioxidants; 0/Azoles; 0/Organoselenium Compounds; 60940-34-3/ebselen; 83-44-3/Deoxycholic Acid; 9035-51-2/Cytochrome P-450 Enzyme System; EC 2.6.1.2/Alanine Transaminase; EC 3.1.3.1/Alkaline Phosphatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Affinities of dihydrocodeine and its metabolites to opioid receptors.
Next Document:  Behavioural effects in rodents of methyl angolensate: a triterpenoid isolated from Entandrophragma a...